Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
THC expands into business aviation as the natural next step of its growthTHC and Bombardier signed a Letter of Intent (LOI) toward firm order for 12 aircraft including 5 Challenger 3500, 5 Global 5500...
-
Point-of-care molecular diagnostics market size is projected to reach USD 17.94 Bn by 2034 from its value of USD 8.46 billion in 2024, at a CAGR of 8.70%
-
Dublin, July 14, 2026 (GLOBE NEWSWIRE) -- The "Dye-Free and Label-Free Packaging for Polymerase Chain Reaction (PCR) Optimization Market Report 2026" has been added to ResearchAndMarkets.com's...
-
Dublin, July 13, 2026 (GLOBE NEWSWIRE) -- The "Non-Invasive Prenatal Testing Market (By Product, Gestation Period, Pregnancy Risk, Technology, Application, End User, and Region), Key Company...
-
VANCOUVER, British Columbia and SUDBURY, Ontario, July 09, 2026 (GLOBE NEWSWIRE) -- Canada has the critical minerals needed for electric vehicles, clean energy, defence systems, and digital...
-
TORONTO, July 09, 2026 (GLOBE NEWSWIRE) -- MDA Space Ltd. (“MDA Space” or the “Company”) (TSX:MDA) (NYSE:MDA), a trusted mission partner to the rapidly expanding global space industry, announced...
-
TORONTO, July 08, 2026 (GLOBE NEWSWIRE) -- MDA Space Ltd. (“MDA Space” or the “Company”) (TSX:MDA) (NYSE:MDA), a trusted mission partner to the rapidly expanding global space industry, announced...
-
Austin, United States, July 03, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, The Fluorescent In Situ Hybridization Probe Market was valued at USD 1,034.61 Million in 2025 and is expected to...
-
Austin, TX, USA, June 29, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Hematologic Malignancies Testing Market Size, Trends and Insights By Product...
-
Appointment supports planned Biologics License Application (BLA) submission in the fourth quarter of 2026 and potential 2027 launch of aglatimagene besadenovec in localized prostate cancer NEEDHAM,...